Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy.
Qian Y, Sun Y, Shi P, Zhou X, Zhang Q, Dong Q, Jin S, Qiu L, Niu X, Zhou X, Zhao W, Wu Y, Zhai W, Gao Y.
Qian Y, et al. Among authors: zhai w.
Acta Pharm Sin B. 2024 Mar;14(3):1150-1165. doi: 10.1016/j.apsb.2023.12.011. Epub 2023 Dec 19.
Acta Pharm Sin B. 2024.
PMID: 38486998
Free PMC article.